Can a common ED drug help COPD patients breathe easier?

NCT ID NCT05844462

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether tadalafil, a drug often used for erectile dysfunction, can help people with severe pulmonary hypertension caused by chronic obstructive pulmonary disease (COPD). About 200 adults with both conditions will receive either tadalafil or a placebo daily for 16 weeks. The main goal is to see if the drug improves how far they can walk in six minutes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Tadalafil
What this could lead to
If it works, this could provide a new treatment option to improve exercise capacity in people with severe pulmonary hypertension due to COPD.
What could go wrong
This is a phase 3 trial, but previous studies of similar drugs in COPD-related PH have shown mixed results. Tadalafil may not improve walking distance and could cause side effects like headache or low blood pressure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kremlin Bicêtre

    RECRUITING

    Le Kremlin-Bicêtre, France, 94270, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.